MINNEAPOLIS--(BUSINESS WIRE)--Leading the development of endovascular aortic repair (EVAR), Medtronic, Inc. (NYSE: MDT) today announced the start of its U.S. post-approval study of the Endurant® AAA Stent Graft System, a medical device used to treat abdominal aortic aneurysms (AAA).
